1. Home
  2. AVK vs CTKB Comparison

AVK vs CTKB Comparison

Compare AVK & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVK
  • CTKB
  • Stock Information
  • Founded
  • AVK 2003
  • CTKB 1990
  • Country
  • AVK United States
  • CTKB United States
  • Employees
  • AVK N/A
  • CTKB N/A
  • Industry
  • AVK Trusts Except Educational Religious and Charitable
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AVK Finance
  • CTKB Health Care
  • Exchange
  • AVK Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • AVK 547.4M
  • CTKB 508.9M
  • IPO Year
  • AVK N/A
  • CTKB 2021
  • Fundamental
  • Price
  • AVK $12.42
  • CTKB $4.15
  • Analyst Decision
  • AVK
  • CTKB Hold
  • Analyst Count
  • AVK 0
  • CTKB 4
  • Target Price
  • AVK N/A
  • CTKB $6.00
  • AVG Volume (30 Days)
  • AVK 112.9K
  • CTKB 1.1M
  • Earning Date
  • AVK 01-01-0001
  • CTKB 08-06-2025
  • Dividend Yield
  • AVK 11.85%
  • CTKB N/A
  • EPS Growth
  • AVK N/A
  • CTKB N/A
  • EPS
  • AVK N/A
  • CTKB N/A
  • Revenue
  • AVK N/A
  • CTKB $196,035,000.00
  • Revenue This Year
  • AVK N/A
  • CTKB $0.74
  • Revenue Next Year
  • AVK N/A
  • CTKB $7.85
  • P/E Ratio
  • AVK N/A
  • CTKB N/A
  • Revenue Growth
  • AVK N/A
  • CTKB N/A
  • 52 Week Low
  • AVK $9.24
  • CTKB $2.37
  • 52 Week High
  • AVK $12.16
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • AVK 58.78
  • CTKB 62.42
  • Support Level
  • AVK $12.24
  • CTKB $3.91
  • Resistance Level
  • AVK $12.47
  • CTKB $4.17
  • Average True Range (ATR)
  • AVK 0.10
  • CTKB 0.20
  • MACD
  • AVK -0.00
  • CTKB -0.00
  • Stochastic Oscillator
  • AVK 64.44
  • CTKB 78.99

About AVK Advent Convertible and Income Fund

Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: